Sanjay Agrawal, a scientific advisor for the US-based Alkomex GBN Pharma Group and an Ahmedabad-based researcher, has filed for a patent for an anti-aging drug formulation aimed at combating aging at the cellular level. The formulation is designed to address the underlying biological processes of aging, potentially offering a groundbreaking approach to age-related issues.
The patent application has been submitted to the Indian Patent Office, marking an important step in the development of this novel treatment. If granted, this patent would secure intellectual property rights for the formulation, allowing Agrawal and the associated pharmaceutical group to potentially commercialize the drug and offer it as a solution to slow or reverse cellular aging.
Agrawal, already holds over 42 patents for unique drug formulations. He claims that other than addressing ageing at a cellular level, this drug has the potential to significantly improve skin health and boost energy levels and enhance overall vitality.
He explained that while chronological ageing is inevitable, biological and psychological ageing differ significantly from one individual to another, influenced by intrinsic and extrinsic factors such as hormonal changes, stress, and lifestyle.
Currently the demand for anti-aging treatments is increasing rapidly in market. This development could spark significant interest in the pharmaceutical industry. However, the drug will undergo extensive testing and regulatory approval to be fully realized in the market, which could take several years.
patent
Longi sues JinkoSolar for infringement of new patent technology
Longi, has filed lawsuits against JinkoSolar for their patent infringement, both the companies are leading players in the solar industry. The legal actions have been initiated in both countries China and the United States.
In China, Longi has filed the lawsuit at the Jinan Intermediate People’s Court in Shandong and requested an immediate halt to the manufacturing, sales, and offers to sell the allegedly infringing products and other related activities to it. The Court has accepted the case, with an expected trial date of March 20.
In the United States, the lawsuit was filed at the U.S. District Court for the Eastern District of Texas, alleging patent infringement of Jinko Solar’s TOPCon and multiple other unspecified photovoltaic module products.
Longi claims that JinkoSolar has infringed upon its intellectual property (IP) related to solar technology, specifically patents concerning the production and design of solar cells and panels. This dispute comes out as both companies are at the forefront of solar technology innovation. The patents plays a critical role in protecting advancements in the highly competitive solar energy sector.
The lawsuits highlight the ongoing tensions in the renewable energy industry, where patent disputes are becoming increasingly common as companies rush to secure a competitive edge in the rapidly growing market for solar energy products. In these types of cases, the outcome can impact product sales, partnerships, and overall market positioning for the companies involved.
It remains to be seen how these lawsuits will unfold, but they signal the importance of intellectual property rights in the clean energy sector.
In China, Longi has filed the lawsuit at the Jinan Intermediate People’s Court in Shandong and requested an immediate halt to the manufacturing, sales, and offers to sell the allegedly infringing products and other related activities to it. The Court has accepted the case, with an expected trial date of March 20.
In the United States, the lawsuit was filed at the U.S. District Court for the Eastern District of Texas, alleging patent infringement of Jinko Solar’s TOPCon and multiple other unspecified photovoltaic module products.
Longi claims that JinkoSolar has infringed upon its intellectual property (IP) related to solar technology, specifically patents concerning the production and design of solar cells and panels. This dispute comes out as both companies are at the forefront of solar technology innovation. The patents plays a critical role in protecting advancements in the highly competitive solar energy sector.
The lawsuits highlight the ongoing tensions in the renewable energy industry, where patent disputes are becoming increasingly common as companies rush to secure a competitive edge in the rapidly growing market for solar energy products. In these types of cases, the outcome can impact product sales, partnerships, and overall market positioning for the companies involved.
It remains to be seen how these lawsuits will unfold, but they signal the importance of intellectual property rights in the clean energy sector.
Innocan Pharma secure first patent in India for Liposome Injection
Innocan Pharma Corporation has granted its first patent in India for its Liposomal CBD Injection platform. This patent protects the company’s synthetic Cannabidiol-loaded Liposome Injection Platform (LPT-CBD), designed for precise dosing and sustained release of synthetic CBD into the bloodstream.
The LPT-CBD platform has received positive feedback from the U.S. Food and Drug Administration (FDA) following a successful pre-Investigational New Drug (pre-IND) meeting, advancing its development as a non-opioid alternative for chronic pain management.
Developed in collaboration with Professor Chezy Barenholz and Dr. Ahuva Cern from the Hebrew University in Jerusalem, the liposomal drug delivery platform allows for prolonged exposure and maximizes the bioavailability and therapeutic effects of cannabinoids.
This granted patent enhances Innocan’s proprietary value in India’s $55 billion pharmaceutical market, complementing its global patent applications and strengthening its position in the cannabinoid-based therapeutic sector.
Innocan Pharma’s CEO, Iris Bincovich, expressed his views about the patent grant and highlighted the company’s commitment to innovation and the advancement of non-opioid alternatives for chronic pain management.
This development in IP underscores Innocan Pharma’s dedication to expanding its intellectual property portfolio and advancing cannabinoid-based therapies on a global scale.
IT Stock jump after a Patent for new data processing technology
Intense Technologies Ltd. has granted a patent for its invention “Method for Rule-Based Control Processing of Multiple Input Data Ingestions in Parallel,” a development that has positively influenced its stock performance after grant.
Stock Performance Post-Patent Grant:
Share Price Increase: Intense Technologies’ share price rose by approximately 4% after grant of patent, reflecting investor interest in the company’s enhanced technological capabilities.
Current Stock Price: As of February 20, 2025, the stock is trading at ₹94.71, marking a 6.33% increase over the past 24 hours.
Historical Stock Performance:
52-Week Range: The stock has fluctuated between ₹87.66 (low) and ₹178.32(high) over the past year, indicating significant volatility according to market run.
Recent Trends: Over the last three months, the stock has declined by 23.17%, and over the past year, it has decreased by 25.55%.
Investor Considerations:
Although, the recent patent grant has positively impacted the stock price, but it is important to note that Intense Technologies has experienced a 26% decline in share value over the past month.
Before investment in stock of Intense Technologies Ltd, Investors should consider this alongside the company’s financial health, market position, and the potential long-term benefits of the new patent.
In summary, the patent grant may have a favorable short-term effect on Intense Technologies’ share price, but investors should remain mindful of the company’s broader financial performance and market dynamics.
This patent positions Intense Technologies as a leader in large-scale data processing, offering solutions that enhance efficiency and intelligence in data management.
New Technology Patent filed for eco-friendly tire made of eggshells by Stellantis
Stellantis, the automotive giant has filed a patent application in U.S. Patent and Trademark Office for an innovative eco-friendly tire solution that uses eggshells as a key material. This innovative approach to making tires more sustainable by replacing conventional materials like carbon black and silica with calcium oxide (CaO), derived from waste eggshells. This new technology will reduce the environmental impact of its manufacturing processes.
The eggshells are used in combination with other natural ingredients to create a more sustainable tire material. This innovation is particularly important in the context of tires. However, tires are made from various synthetic and petroleum-based materials that contribute to environmental pollution, especially in terms of waste when tires are discarded.
Key Points:
Strength and Durability: The eggshells are made of calcium carbonate, which can provide added strength and stability to the rubber compound, making the tire more durable.
Sustainability: The eggshells is a waste product, which reduce the reliance on synthetic materials and lowers the overall carbon footprint of tire production.
Improved Performance: The invention also suggests that eggshells can enhance traction and fuel efficiency by improving the tire’s performance characteristics.
By incorporating eggshells, the issue of tire waste will solved and by-products or waste from one industry are used in another. This move aligns with the sustainability goals to reduce CO2 emissions and minimize environmental impact across its manufacturing operations.
Although, the eggshell based tire manufacturing is still in its early stages, but if successful, it could have significant implications for the entire automotive and tire industry, potentially leading to greener alternatives for tire production in the future. It also presents a creative way of using biodegradable and abundant waste materials, like eggshells, which are generally discarded.
Honda filed for NWX 125 New Technology Patent in India
Honda has filed a patent application for the NWX 125 scooter in India, which shows indication of potential introduction to the Indian auto market. The NWX 125 is a sporty 125cc scooter currently available in international markets. The features are a sharp front apron, dual LED headlamps, and a single-piece stepped seat. The NWX 125 is powered by a 124cc, single-cylinder engine producing 9.3 BHP and 10 Nm, paired with a continuously variable transmission (CVT). The scooter also includes a digital instrument console and keyless ignition.
Although, the patent filing suggests Honda’s interest in the Indian auto market, but there is no official confirmation of a launch date in India. On introduction, the NWX 125 would compete with models like the TVS Ntorq 125 and Yamaha RayZR 125.
In the meantime, Honda has also filed a patent application for the NT1100 sport-touring motorcycle in India, further indicating the company’s plans to expand its product lineup in the country.
Honda filed for NT1100 new technology patent in India
Honda has filed a patent application in India for the NT1100 Tourer. The bike is already on sale in the European market.
The Honda NT1100 gets sporty style and muscular bodywork. The bike is powered by a 1,084cc parallel-twin engine, delivering nearly 100 horsepower and 116Nm of torque, and offers features such as a TFT display, riding modes, smartphone connectivity, ABS, and traction control. It also includes electronically adjustable Showa front forks and a mono-shock, with braking handled by dual front and a single rear disc mounted on 17-inch wheels.
Although, Honda has not officially announced a launch date for the NT1100 in India, but the design patent filing suggests that the company is about to introduce the model into the Indian auto market. On launch, the NT1100 would compete with other full-sized touring bikes such as the BMW R 1250 RT and the Kawasaki Ninja 1000SX.
Use Of Sanskrit for new patent technology
The Lok Sabha secretariat has decided to provide simultaneous interpretation of parliamentary proceedings in Six different languages including Sanskrit. This introduction of Sanskrit interpretation in the Lok Sabha is a testament to the government’s efforts to bring the language into the mainstream. This initiative can serve as a stepping stone for broader applications of Sanskrit in official, scientific, and legal frameworks and proceedings. As a language if it can facilitate real-time parliamentary debates, why not intellectual property filings? In current era other countries are embracing their linguistic heritage in scientific and technical field. India has the opportunity to take a pioneering step by integrating Sanskrit into its patent system.
Although, Sanskrit itself is not directly related to patent or the legal world in the same way as English or other common languages for intellectual property. However, there are a few reasons why Sanskrit might come up in discussions related to patents or intellectual property, even if it’s not the primary language of patents:
1. Historical Context: Sanskrit is one of the oldest languages in the world and has a rich historical and cultural significance. If a intellectual property involves traditional knowledge, especially from regions where Sanskrit is or was historically used, it may be relevant to discussions on the protection of ancient wisdom or practices. In such cases, Sanskrit could be part of the research or documentation, especially when related to traditional Indian medicine, spiritual practices, or ancient technologies that might be patented.
2. Patent Language Innovation: The Patents are usually filed in legal and technical languages (like English, Chinese, Japanese etc). The creative solutions or innovations described in patents might reference Sanskrit, particularly when the patent involves innovations related to language processing, machine learning, or translation tools for rare or ancient languages. For example, a patent could be related to systems that analyze Sanskrit texts or make them more accessible through modern technology.
3. Symbolic Significance: The companies might use Sanskrit or Sanskrit-based words as part of trademarks and for branding their products and services, especially in tech or pharma industries. If a brand name or concept connected to Sanskrit were part of a larger patent dispute or related to intellectual property rights, it might show up in legal news or patent filings.
4. Technology for Translation: Patents related to AI and natural language processing might be used to improve or automate the translation of ancient languages like Sanskrit into modern languages. This could be valuable in academia, research, and technology, which could tie into the patent landscape.
It can reflects India’s ability to connect its ancient traditions and knowledge with modern needs. By reviving Sanskrit in this modern context, India could underscore the enduring relevance of ancient wisdom in addressing contemporary challenges.
Madras HC Uphold Controller’s Decision Of new AI Patent technology
In a recent judgement, the Madras High Court has upheld the controller’s decision of rejection of a patent application for an invention aimed at integrating human intelligence with artificial intelligence (AI). The applicant, Caleb Suresh Motupalli, had filed a patent application for a system designed to enhance human capabilities by merging human and AI functionalities.
Background of the Invention:
The invention, titled “Necktie Persona-Extender/Environment-Integrator and Method for Super-Augmenting a Persona to Manifest a Pan-Environment Super-Cyborg,” proposed a method to augment human abilities through the integration of AI. The applicant argued that this system would function alongside the user, enhancing both cognitive and physical abilities.
Patent Office Examination:
After examination, the Indian Patent Office issued a First Examination Report (FER) raising objections regarding the applicability, novelty, and compliance of the claimed invention with the provisions of the Patents Act 1970. The applicant made certain amendments to the patent claims and filed for reconsideration. Despite these amendments, the Controller of Patents maintained the objections and refused the application for Patent.
Court’s Decision:
The Madras High Court, presided over by Justice Senthil Kumar Ramamoorthy, dismissed the appeal of restoration of the patent application, stating that there are no sufficient grounds to interfere with the Controller’s decision. The court concluded that the invention lacked sufficient technical detail, clarity, inventive step, and failed to demonstrate patentable subject matter, rendering it non-patentable under the statutory requirements.
Implications:
This decision of the Madras High Court underscores the importance of providing clear and detailed technical features of invention in patent applications, especially in emerging fields like AI integration. It also highlights the necessity for inventions to demonstrate a clear inventive step and technical clarity to meet the patentability criteria under the Patents Act 1970.
Oral Biopsy Device technology Granted a Patent in USPTO
An automated oral biopsy device which is invented by a professor of Siksha ‘O’ Anusandhan (SOA) Deemed to be University in Bhubaneswar has been granted a Patent by United States patent office.
This device is pen-like shape and user-friendly, it simplifies the biopsy process, eliminating the need for extensive instrumentation and incorporating features like tele-screening and fiber-optic lighting.
This device enhance the accuracy and efficiency of oral disease diagnoses, particularly oral cancer, by enabling early detection and treatment without compromising expert opinion. Professor Mohanty had previously secured two Indian patents for the same product in 2023 and 2024, and a design patent in 2019. She filed for the U.S. patent in 2019, which was granted recently.
The research was funded by the Department of Science and Technology for prototype development, with support from Startup Odisha for need-based assistance. This innovation has garnered recognition, including the Global Outreach Dental Innovation Award in 2021, and was showcased at the Global Bio India 2024 in New Delhi.
This useful invention will help the patients immensely with early diagnosis and treatment of oral diseases without compromising on the expert opinion and reducing the burden of oral diseases, specially oral cancer.